The US’ Centers for Disease Control and Prevention (CDC) has disclosed that a limited supply of COVID-19 vaccines could be available before the end of the year.
The agency in a statement released on Monday October 15, 2020, said many vaccines are being developed and tested, but some might be ready before others – CDC is planning for many possibilities.
It explained that the safety of any possible vaccine is “a top priority and supply of a successful vaccine would be increased over months.”
In case of limited supply, the CDC said “some groups may be recommended to get a COVID-19 vaccine first” and experts are working on how to distribute them in “a fair, ethical, and transparent way.”
On 13th October, 2020, the National Institutes of Health which is responsible for biomedical and health research, said it had started a study to determine whether certain approved drugs show promise against COVID-19.
It added that, experimental antiviral drug Remdesivir has demonstrated clinical benefit for patients.
US President Donald Trump was also administered the drug when he was hospitalized after testing positive for virus.